5 blue chip ASX 200 shares to buy in October and hold for 10 years

Let's see why these shares could be great long term options according to analysts.

Key points
  • Analysts identify five ASX 200 blue-chip shares as top long-term picks due to their robust growth potential and strategic market positions.
  • These shares are involved in sectors such as gaming technology, biotechnology, property, and digital platforms, each capitalising on global trends.
  • The companies are expected to deliver sustained earnings growth, supported by strong balance sheets and strategic expansions.

The S&P/ASX 200 index has started the new quarter just shy of record highs.

But that doesn't mean there aren't any blue-chip opportunities out there for investors.

For example, five ASX 200 blue chip shares that analysts think are in the buy zone in October are listed below. Here's why they could be top long-term picks:

Two smiling work colleagues discuss an investment at their office.

Image source: Getty Images

Aristocrat Leisure Ltd (ASX: ALL)

Gaming technology powerhouse Aristocrat Leisure has expanded successfully beyond poker machines in recent years. For example, its acquisition of NeoGames has boosted exposure to the fast-growing real money gaming and online lottery sector. With strong earnings growth expected and resilient cash flow generation, Aristocrat remains a very attractive ASX 200 blue chip share.

Bell Potter is a fan and has a buy rating and $79.00 price target on its shares.

Cochlear Ltd (ASX: COH)

Hearing implant leader Cochlear could be a great buy and hold option. Demand for its devices is rising on the back of ageing populations across the globe and broader access to hearing healthcare. With a robust balance sheet and a track record of delivering both growth and dividends, Cochlear continues to earn its place as a reliable blue-chip holding.

UBS currently rates Cochlear as a buy with a $350.00 price target.

CSL Ltd (ASX: CSL)

Biotech leader CSL has faced pressure in recent months, with investor sentiment hit by the planned spin-off of Seqirus and potential US tariffs on pharmaceutical products. Even so, major brokers remain upbeat, with price targets significantly higher than current levels. And with plasma demand growing, new therapies in the pipeline, and a heavy investment in US manufacturing to reduce risk, CSL continues to stand out as a core long-term holding. Especially while it trades near a 52-week low.

Morgans currently has a buy rating and $293.83 price target on its shares.

Goodman Group (ASX: GMG)

Property giant Goodman Group has capitalised on surging demand for logistics and data centre space. With e-commerce, cloud computing, and AI infrastructure all requiring new developments, Goodman's global pipeline positions it at the heart of these megatrends. Backed by a strong balance sheet and disciplined capital management, this ASX 200 blue chip share looks well-placed to deliver sustained growth over the next decade.

Bell Potter is bullish and has a buy rating and $40.80 price target on its shares.

REA Group Ltd (ASX: REA)

Finally, REA Group has cemented itself as the go-to digital property platform in Australia. Pricing power, growth in adjacent services, and expansion offshore have helped it sustain double-digit earnings growth. And with the housing market expected to boom as interest rates fall, the coming years look likely to be very positive.

Bell Potter is also bullish on this one. It has a buy rating and $284.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in CSL, Cochlear, Goodman Group, and REA Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, and Goodman Group. The Motley Fool Australia has recommended CSL, Cochlear, and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Person holding a blue chip.
Blue Chip Shares

Fortescue vs National Australia Bank: Which ASX blue chip is the better buy this month?

Fortescue vs National Australia Bank: Which one gets my nod as the better buy right now?

Read more »

Cheerful boyfriend showing mobile phone to girlfriend with a coffee mug in dining room.
Blue Chip Shares

Why I'd buy CBA and Coles shares in October

I take a closer look at two ASX shares I would consider putting fresh money into this month.

Read more »

Blue chip in a trolley with a man pushing it.
Blue Chip Shares

Commonwealth Bank vs BHP: Which ASX blue chip is the better buy in October?

Which company has the edge in my October ASX blue-chip comparison?

Read more »

Male hands holding Australian dollar banknotes, symbolising dividends.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These large businesses have a lot of positives.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Blue Chip Shares

CBA vs Telstra: Which ASX blue-chip is better for passive income?

Commonwealth Bank or Telstra for your next passive income buy? I compare yields, franking, and my top pick for income…

Read more »

Woman and man at work looking at data on a tablet at work.
Opinions

Buy, hold, sell: BHP, CSL, and Westpac shares

I take a closer look at how I would approach these three major ASX shares today.

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Blue Chip Shares

Could Wesfarmers shares reach $100 in 2027

I crunch the numbers to see what it would take for the retail giant to reach triple figures.

Read more »

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These major businesses are solid options for dividends…

Read more »